Findings

What do systematic reviews say?

1,139 questions · 1,173 findings · 89 reviews · Neuromuscular

Sort:Best matchNewestHighest certainty Download CSV

No studies found 302 · 25.7%GRADE not reported 119 · 10.1%Very low 267 · 22.8%Low 239 · 20.4%Moderate 177 · 15.1%High 69 · 5.9%

Low‐level laser therapy and a splint vs placebo and a splint

Overall improvement in CTS: SSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 112 participants
Very low

Low‐level laser therapy and a splint vs placebo and a splint

Overall improvement in CTS: SSS: long term ‐ not measured · carpal tunnel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐level laser therapy and a splint vs placebo and a splint

Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 112 participants
Very low

Low‐level laser therapy and a splint vs placebo and a splint

Overall improvement in CTS: FSS: long term ‐ not reported · carpal tunnel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐level laser therapy and a splint vs placebo and a splint

Adverse events · carpal tunnel syndrome

It is very uncertain whether low‐level laser therapy and a splint changes adverse events compared with placebo and a splint (very low certainty).

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
RR 2 [0.38, 10.48]
1 study · 112 participants
Very low

Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6

Overall improvement in CTS: SSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Very low

Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6

Overall improvement in CTS: SSS: long term ‐ not measured · carpal tunnel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6

Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Very low

Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6

Overall improvement in CTS: FSS: long term ‐ not reported · carpal tunnel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐level laser therapy vs placebo

Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 159 participants
Very low

Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6

Adverse events · carpal tunnel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐level laser therapy vs placebo

Overall improvement in CTS: FSS: long term Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

Low‐level laser therapy vs placebo

Adverse events · carpal tunnel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐level laser therapy vs ultrasound

Overall improvement in CTS: SSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 127 participants
Very low

Low‐level laser therapy vs ultrasound

Overall improvement in CTS: SSS: long term Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Low‐level laser therapy vs ultrasound

Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 127 participants
Very low

Low‐level laser therapy vs ultrasound

Overall improvement in CTS: FSS: long term Scale from: 1 to 5 · carpal tunnel syndrome

1 finding from 1 review

Low‐level laser therapy for carpal tunnel syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Corticosteroids vs control

Improvement in disability grade after 4 weeks · patients with Guillain‐Barré syndrome

4 findings from 1 review

Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 587 participants
Moderate
Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 120 participants
Very low
Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 467 participants
Moderate

Show 1 more finding

Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
RR 1.08 [0.93, 1.24]
5 studies · 567 participants
Moderate

Corticosteroids vs control

Death or disability after 1 year · patients with Guillain‐Barré syndrome

Corticosteroid showed no clear difference in death or disability after 1 year compared with control (moderate certainty).

1 finding from 1 review

Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
RR 1.51 [0.91, 2.5]
3 studies · 491 participants
Moderate

Corticosteroids vs control

Adverse events ‐ Diabetes mellitus requiring insulin · patients with Guillain‐Barré syndrome

Corticosteroid leads to higher adverse events ‐ diabetes mellitus requiring insulin compared with control (high certainty).

1 finding from 1 review

Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
RR 2.21 [1.19, 4.12]
2 studies · 467 participants
High